Meet Dr. Apurba Ganguly
He built OPTM around a simple idea: measure the muscle biology behind the pain, then treat that — without surgery.
Non-surgical pain care using phytotherapy and blood biomarkers, not another scan-and-refer loop.
Pain clinician, biochemist, and the person who designed this protocol
"Most chronic pain is biology we can measure. We use blood biomarkers and muscle age, then treat with plant-based compounds and movement — not a knife, and not another painkiller prescription."Dr. Apurba Ganguly, Founder - OPTM Healthcare
Published Research
Peer-reviewed papers in international journals.
Global Patents
Treatment methods filed as patents outside India.
Years Experience
Pain biochemistry first, then clinic work.
Patients Treated
People treated without a joint replacement.
How the protocol was built
Started pain biochemistry research
Medical College
First biomarker protocol in clinic
Research Institute
Brought AI diagnostics into the OPTM protocol
OPTM Healthcare
100,000+ Patients Treated Across OPTM Clinics
Delhi, Kolkata, Panchkula
What clinical expertise means in a patient visit
Expertise is not a diagnosis based on an image alone. At OPTM, the clinical process begins by listening to the pattern of pain, reviewing the medical history, examining the affected area, and identifying whether the presentation is appropriate for a non-surgical pathway. Imaging and laboratory findings are interpreted as parts of that assessment rather than as a stand-alone verdict.
For knee pain, that can mean separating early-stage degenerative change from a ligament, tendon, inflammatory, or post-traumatic problem. For spine pain, it can mean checking whether symptoms point to a mechanical, neurological, referred, or systemic source. The resulting plan may combine biomarker review, guided movement, load management, manual or physical therapy, and carefully selected phytotherapeutic options.
A responsible expert also identifies when not to continue a non-surgical approach. Advanced arthritis, progressive neurological loss, infection, fracture, severe instability, or rapidly worsening symptoms may require imaging review, a surgical opinion, or another medical specialty. The aim is not surgery avoidance at any cost; it is appropriate, measurable, and safer care.
1. Establish the baseline
Record symptoms, function, relevant diagnoses, previous treatment, examination findings, and available investigation results. A clear baseline makes later change measurable and reduces the risk of attributing improvement to the wrong intervention.
2. Match the protocol to the problem
Not every pain condition responds to the same combination of tests, movement, and plant-based formulations. Treatment is staged around the diagnosis, disease grade, risk factors, and the patient's own goals for daily activity.
3. Review and escalate
Follow-up should include a documented change in pain, function, mobility, or relevant markers. If the expected response is absent, the plan should be reassessed and the patient referred when the clinical picture falls outside the scope of non-surgical care.
In the documented cohort of more than 1,000 Grade 1-3 knee patients observed from 2019 to 2024, 89% avoided a knee-replacement recommendation after the OPTM protocol. This cohort-specific figure provides useful context, but it does not predict the outcome for every patient or every stage of osteoarthritis.
Sit with the team that built this protocol
100,000+ patients have gone through Dr. Ganguly's bloodwork-first, drug-free protocol. No surgery. No steroid series. No opioid script.
What we can actually show you
35+ years of research, published papers, and clinic outcomes — not a slogan.
Patients Treated Across OPTM Clinics
Knee-Replacement Avoidance in Documented Grade 1-3 Cohort
Years of pain biochemistry research
Published Medical Research Papers